




Searching News Database: Geron
HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
HSMN NewsFeed - 6 Jan 2017
Viking Therapeutics Announces Senior Level Appointments to Management Team
Viking Therapeutics Announces Senior Level Appointments to Management Team
HSMN NewsFeed - 9 Jul 2014
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors
Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors
HSMN NewsFeed - 20 Jun 2013
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 6 Mar 2012
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 18 Jun 2009
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
HSMN NewsFeed - 23 Oct 2007
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 3 Oct 2007
Endologix Announces Successful Powerlink Deployments with Advanced Visiflex Integrated System
Endologix Announces Successful Powerlink Deployments with Advanced Visiflex Integrated System
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 17 Jan 2007
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
HSMN NewsFeed - 17 Oct 2006
Detroit Receiving Offers Michigan's First Hospital-Based Hyperbaric Wound Care Program
Detroit Receiving Offers Michigan's First Hospital-Based Hyperbaric Wound Care Program
HSMN NewsFeed - 19 Jul 2006
Myriad's 24-Month Study of Flurizan Demonstrates Significant Benefit in Alzheimer's Disease Patients
Myriad's 24-Month Study of Flurizan Demonstrates Significant Benefit in Alzheimer's Disease Patients
HSMN NewsFeed - 22 Jun 2006
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
HSMN NewsFeed - 19 May 2006
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Additional items found! 56

Members Archive contains
56 additional stories matching:
Geron
(Password required)
Geron
(Password required)